| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |